AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • March 18th, 2013 • Albany Molecular Research Inc • Services-commercial physical & biological research • New York
This AMENDED EMPLOYMENT AGREEMENT (the “Agreement”) is made this 17th day of September 2012 (the “Effective Date”) and amended on December 27, 2012, by and between Albany Molecular Research, Inc., a Delaware corporation (the “Company”), and Michael M. Nolan (the “Executive”).
DEVELOPMENT AND SUPPLY AGREEMENT BY AND BETWEEN ORGANICHEM CORP. and PUREPAC PHARMACEUTICAL CO. Dated: May 10, 2000Development and Supply Agreement • March 18th, 2013 • Albany Molecular Research Inc • Services-commercial physical & biological research • New York
THIS AGREEMENT (the Agreement) is entered into as of May 10, 2000 (the Effective Date) between Organichem Corp, (Organichem), a Delaware corporation with a principal place of business at 33 Riverside Avenue, Rensselaer, New York 12144, and Purepac Pharmaceutical Co a Delaware corporation with a principal place of business at 200 Elmora Avenue, Elizabeth, New Jersey 07207 (Purepac).
SUPPLY AGREEMENT PARTIESSupply Agreement • March 18th, 2013 • Albany Molecular Research Inc • Services-commercial physical & biological research • New York
GE Healthcare entity (thereinafter ”GEHC”), previously known as Amersham Health AS: GE HEALTHCARE AS Address Nycoveien 1-2 0401 OSLO NORWAY Other Party (thereinafter the “Supplier”), previously known as Organichem Corporation: AMRI Rensselaer, Inc. Address 26 Corporate Circle Albany, New York 12203 USA
NON-QUALIFIED STOCK OPTION AGREEMENT UNDER THE ALBANY MOLECULAR RESEARCH, INC.Non-Qualified Stock Option Agreement • March 18th, 2013 • Albany Molecular Research Inc • Services-commercial physical & biological research
Pursuant to the Albany Molecular Research, Inc. 2008 Stock Option and Incentive Plan, as amended through the date hereof (the “Plan”), Albany Molecular Research, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or any part of the number of shares of Common Stock, par value $.01 per share (the “Stock”), of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
RESTRICTED STOCK AWARD AGREEMENT NON-EMPLOYEE DIRECTORS UNDER THE ALBANY MOLECULAR RESEARCH, INC.Restricted Stock Award Agreement • March 18th, 2013 • Albany Molecular Research Inc • Services-commercial physical & biological research
Pursuant to the Albany Molecular Research, Inc. 2008 Stock Option and Incentive Plan, (the “Plan”) as amended through the date hereof, Albany Molecular Research, Inc. (the “Company”) hereby grants a Restricted Stock Award (an “Award”) to the Grantee named above. Upon acceptance of this Award, the Grantee shall receive the number of shares of Common Stock, par value $0.01 per share (the “Stock”), of the Company specified above, subject to the restrictions and conditions set forth herein and in the Plan.
